最近,我在「TIME時代」雜志的專欄文章裡,向全球的讀者介紹了大陸「世界工廠」的+AI自動化升級。隨著勞動力成本的上漲,工業自動化、智慧化勢必是大陸製造業的一劑特效藥。自動化能讓運營成本下降,但仍能讓中國大陸保持生產品質、流程、供應鏈維度的優勢。AI賦能產業升級的願景或許還需多年才能實現,但當下的大陸已經讓未來可期。
以下是專欄文章全文,經TIME授權翻譯轉載:
「中國世界工廠 + AI 的未來」
多年來,中國大陸一直被喻為「世界工廠」,即便在全球其他經濟體紛紛遭遇新冠疫情重擊的2020年,大陸製造產業仍然維持穩健的增長范式,全年產值高達3.854萬億美元,占到全球市場近三分之一。
但如果你腦中的大陸工廠是傳統的「血汗工廠」,是時候修正你的刻板印象了。大陸經濟已經迅速地從疫情衝擊下復蘇,疫情同時催化了各種各樣人工智慧(AI)的應用場景加速實現。自2014年以來,中國大陸的AI專利申請量已經超越美國,至今維持全球領先。在學術領域,中國大陸的AI研究論文發表數量、AI期刊的引用量,也雙雙在近年超過了美國。在產業方面,AI應用在大陸的落地速度超越世界其他國家和地區,具有商業價值的AI應用如今開始百花齊放,整合了軟體、硬體和機器人技術的新一代自動化揭開序曲,AI賦能傳統行業的能量,正在蓄勢待發地重塑各行各業。
人類社會至今經歷了三次不同的工業革命:蒸汽革命、電力革命和資訊革命。我相信,AI將會是推動全球第四次工業革命的核心引擎,在世界各地點燃數位化和自動化的變革,而這波前所未有的硬科技浪潮,將由中國來引領實踐。
由於勞動人口減少和新增人口放緩,中國大陸的傳統產業正面臨著勞動力成本上升的巨大壓力,AI正是解決這個難題的技術解答。人工智慧不僅能夠降低運營成本,提高生產效率,擴大整體產能,還有望能帶來收入的增長。
例如,創新工場投資的廣州極飛科技是一家致力於未來農業的AI科技公司,極飛將無人機、機器人和感測器部署在稻田、麥田和棉花田裡,用技術賦能農業中的播種、農藥噴灑、栽種管理、甚至天氣監測環節。用於作物噴灑的極飛科技R150農業無人車已經被推廣到了英國,應用在蘋果、草莓、黑莓等多種經濟作物的種植流程中。
一些大陸的創新公司正積極把機器人拓展到意想不到的場景。總部位於北京的鎂伽是創新工場投資的生命科學智慧自動化公司,他們和實驗室、製藥公司、高校合作,憑藉AI+機器人技術的積累,用自動化解決方案執行實驗室中勞動密集、重複性高、但需要高度精確的任務和流程,同時機器人作業也將盡最大可能保護實驗室人員降低實驗過程中的感染風險。
除了創業公司,我們看到幾家成熟的龍頭企業也開始積極擁抱AI。創新工場參與了有28年歷史的中力電動叉車,這家頭部的鋰電叉車製造商已經推出了能夠在工廠、倉庫自主運行的無人叉車,並且無需對運行環境進行改造,能快速實現從手動到電動到自動駕駛的搬運賦能創新。此外,擁有50多年歷史的領先客車製造商-宇通集團,與自動駕駛獨角獸企業-文遠知行戰略合作,已在大陸三個城市的馬路上運行全無人駕駛小巴。
接著會發生什麼?我大膽預見,在更長遠的未來,機器人和AI將接管大多數產品的製造、設計、交付甚至營銷——很可能將生產成本降低到和原物料成本相差無幾。未來的機器人有能力自我複製和自我修復,甚至做到部分自我反覆運算設計。房屋和公寓將交由AI主導設計,使用預製建築模塊,交由機器人像搭積木似地築樓蓋房。無人公交、無人摩托等隨傳隨到的自動化未來交通系統,能將我們安全無虞地送達想去的地方。
這些願景成為現實或許還需要多年,但此時的大陸正在積極鋪墊引領新一代自動化革命的基石。可期的是,中國工廠的實力將不僅僅體現在產能上,而將逐步彰顯在智慧上。
本文經「TIME時代」授權進行中文編譯,原文如下:
China Is Still the World's Factory — And It's Designing the Future With AI
BY KAI-FU LEE
For many years now, China has been the world’s factory. Even in 2020, as other economies struggled with the effects of the pandemic, China’s manufacturing output was $3.854 trillion, up from the previous year, accounting for nearly a third of the global market.
But if you are still thinking of China’s factories as sweatshops, it’s probably time to change your perception. The Chinese economic recovery from its short-lived pandemic blip has been boosted by its world-beating adoption of artificial intelligence (AI). After overtaking the U.S. in 2014, China now has a significant lead over the rest of the world in AI patent applications. In academia, China recently surpassed the U.S. in the number of both AI research publications and journal citations. Commercial applications are flourishing: a new wave of automation and AI infusion is crashing across a swath of sectors, combining software, hardware and robotics.
As a society, we have experienced three distinct industrial revolutions: steam power, electricity and information technology. I believe AI is the engine fueling the fourth industrial revolution globally, digitizing and automating everywhere. China is at the forefront in manifesting this unprecedented change.
Chinese traditional industries are confronting rising labor costs thanks to a declining working population and slowing population growth. The answer is AI, which reduces operational costs, enhances efficiency and productivity, and generates revenue growth.
For example, Guangzhou-based agricultural-technology company XAG, a Sinovation Ventures portfolio company, is sending drones, robots and sensors to rice, wheat and cotton fields, automating seeding, pesticide spraying, crop development and weather monitoring. XAG’s R150 autonomous vehicle, which sprays crops, has recently been deployed in the U.K. to be used on apples, strawberries and blackberries.
Some companies are rolling out robots in new and unexpected sectors. MegaRobo, a Beijing-based life-science automation company also backed by Sinovation Ventures, designs AI and robots to safely perform repetitive and precise laboratory work in universities, pharmaceutical companies and more, reducing to zero the infection risk to lab workers.
It’s not just startups; established market leaders are also leaning into AI. EP Equipment, a manufacturer of lithium-powered warehouse forklifts founded in Hangzhou 28 years ago, has with Sinovation Ventures’ backing launched autonomous models that are able to maneuver themselves in factories and on warehouse floors. Additionally Yutong Group, a leading bus manufacturer with over 50 years’ history, already has a driverless Mini Robobus on the streets of three cities in partnership with autonomous vehicle unicorn WeRide.
Where is all this headed? I can foresee a time when robots and AI will take over the manufacturing, design, delivery and even marketing of most goods—potentially reducing costs to a small increment over the cost of materials. Robots will become self-replicating, self-repairing and even partially self-designing. Houses and apartment buildings will be designed by AI and use prefabricated modules that robots put together like toy blocks. And just-in-time autonomous public transportation, from robo-buses to robo-scooters, will take us anywhere we want to go.
It will be years before these visions of the future enter the mainstream. But China is laying the groundwork right now, setting itself up to be a leader not only in how much it manufactures, but also in how intelligently it does it.
Source:https://time.com/6084158/china-ai-factory-future/
「partnership company中文」的推薦目錄:
partnership company中文 在 Anchor Taiwan Facebook 的最讚貼文
【 Cloud Gaming Battle | #雲端串流遊戲 #台灣贏家 】
.
🎮 With major players like Microsoft and Google in the field, one #Taiwan-based company is winning the game.
.
Partnered with both Japan and South Korea’s leading telecom companies, as well as #Alibaba and #Nintendo, the cloud service provider is ready for the 5G battle.
.
More about Ubitus Inc.:
➢ Partnership with Alibaba Cloud https://prn.to/39hRZ2v
➢ 中文內容 https://bit.ly/2Mr6xmf
-
🎯 Anchor Taiwan | Tech x Culture x Venture
🚀 Next up: Hardware (May), Climate (October)
#5G #GamingOnDemand #Subscription #AnchorTaiwan
partnership company中文 在 台灣光鹽生物科技學苑 Facebook 的最讚貼文
今年的藥物安全系列課程來啦‼️ 熱騰騰的消息小編趕快告訴大家👍 機會難得千萬要把握呀‼️
2019/12/3 (二)【藥物安全系列 】-新藥臨床開發及上市後之國際藥物安全監視實務
【Drug Safety Series 】- International Pharmacovigilance Practices from New Drug Clinical Development to Post-Marketing
報名方式On-line Registration :
https://slbiotech.pse.is/MN8XA
主辦單位:台灣光鹽生物科技學苑Taiwan Salt and Light Biotech Institute
課程地點:光鹽會議中心Salt and Light Conference Center
課程日期:108年12月3日(二) 3rd Dec. 2019 (Tue.) 09:00-17:00
☆議程大綱Topics
一、國際安全監視查核/稽核實務International Pharmacovigilance Audits/Inspections
1.如何進行國際藥物安全監視查核/稽核前準備(英文授課) Preparation prior to the audit/inspection (Dr. Meik Helmut Behrens)
2.國際藥物安全查核/稽核之應對(英文授課) Reception/reaction during audit/inspection (Dr. Meik Helmut Behrens)
3.藥物安全查核/稽核之應對演練(中英文進行)audit/inspection role-plays -稽/查核員、被訪談人、第三者觀察員 (伍亮霓召集人-Liang-Ni Wu)
4.國際藥物安全查核/稽核缺失處置與追蹤 (英文授課) Management and follow-up of the findings (Dr. Meik Helmut Behrens)
二、藥物安全數據資料庫(英文授課) Safety database (Dr. Meik Helmut Behrens)
三、新藥開發合作廠商之臨床試驗藥物安全數據交換要求(英文授課) Safety data exchange requirements in clinical trials for clinical development partnership (伍亮霓召集人-Liang-Ni Wu)
四、Panel Discussion (中文進行):
台灣藥物安全之法規層面與執行層面如何與國際接軌
How do the Taiwanese health authority and industry regulate and execute
pharmacovigilance/drug safety in line with international standards
The experts will discuss from the below perspectives:
o 從衛生主管機關執行單位的角度Taiwanese health authority/agency
o 從台灣生技藥業進行新藥開發臨床試驗的角度Taiwanese biotech/pharma companies conducting new drug development clinical trials
o 從與國際藥廠合作之台灣代理經銷商的角度Taiwanese distributors/ sales agents for international pharma companies
o 從國際藥廠的角度International pharma company
*Panel Discussion 與談人:台灣光鹽生技學苑 蔡佩珊執行長、財團法人藥害救濟基金會藥物安全組 黃薇伊組長、安成生物科技股份有限公司臨床研究處 林宜瑩處長、台灣光鹽生技學苑國際合作組 伍亮霓召集人Liang-Ni Wu
☆講師Speakers:
*Dr. Meik Helmut Behrens (來自德國任職於國際藥廠之藥物安全專家)
Pharmacovigilance Expert from Germany, with more than 13years of industrial experience of global drug safety /pharmacovigilance within a pharmaceutical company and contract research organization.
*伍亮霓Liang-Ni Wu(任職德國國際藥廠之藥物安全專家,台灣光鹽生技學苑國際合作組)
Pharmacovigilance Alliance Manager from Taiwan (based in Germany), with 6 years of industrial experience in medical writing / regulatory affairs and 10years of drug safety/ pharmacovigilance experience within a pharmaceutical company and contract research organizations.
課程費用Registration Fee: 4500 NT/person( Lunch and coffee/tea breaks included in registration fee)
學苑信箱:bioschool@biotech-edu.com 學苑電話:02-2545-9721
partnership company中文 在 By ASQ Consulting Group | 需付更多所得税负无限债务! 你还 ... 的推薦與評價
需付更多所得税负无限债务! 你还在傻傻的用Sole proprietor和 Partnership 开公司? Sole proprietor 是独资生意;企业拥有人和公司是一体的, ... ... <看更多>
partnership company中文 在 如何選擇適合自己的公司類型?独资公司Sole Proprietorship 的推薦與評價
美國的公司簡單來說主要有:Sole Proprietorship獨資公司、 Partnership 合夥公司、LLC有限公司、S Corporation 和C Corporation 等。 ... <看更多>